新生儿重症监护病房益生菌使用与安全性:匹配队列研究
该多中心队列研究纳入1997至2016年289个新生儿重症监护病房收治的23-29周早产儿,评估益生菌使用随时间的变化及其与不良结局的关联。结果显示益生菌使用率上升,且与坏死性小肠结肠炎和死亡风险降低相关,但与念珠菌感染风险增加相关。
要点
- 早产儿益生菌使用率从1997至2016年逐渐上升,各NICU间存在差异。
- 益生菌暴露与坏死性小肠结肠炎(OR 0.62)和死亡(OR 0.52)风险降低相关。
- 益生菌暴露与念珠菌感染风险增加相关(OR 2.23),但血流感染和脑膜炎风险未增加。
核心结论
- 益生菌使用随时间增加,并与坏死性小肠结肠炎和死亡风险降低相关。
研究设计与样本
- 将益生菌暴露儿与同 postnatal day 接受肠内喂养的未暴露儿进行匹配,采用条件逻辑回归分析。
主要发现
- 益生菌暴露与NEC风险降低相关(OR 0.62,95%CI 0.48-0.80)。
- 益生菌暴露与死亡风险降低相关(OR 0.52,95%CI 0.39-0.70)。
- 益生菌暴露与念珠菌感染风险增加相关(OR 2.23,95%CI 1.29-3.85)。
临床怎么用
- 在早产儿中使用益生菌可能降低NEC和死亡风险,但需警惕念珠菌感染风险增加。
- 需针对特定益生菌产品开展前瞻性随机对照研究以进一步评估安全性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the prevalence of probiotic administration in infants born preterm over time, as well as the association between probiotic administration and select adverse outcomes. STUDY DESIGN: We performed a multicenter cohort study of infants 23-29 weeks of gestational age admitted to 289 neonatal intensive care units from 1997 to 2016. We evaluated the type of probiotics given and prevalence of exposure to probiotics over time and by site. We matched infants exposed to probiotics by several factors to unexposed infants receiving enteral feeds on the same postnatal day. We performed conditional logistic regression to evaluate the association between probiotics exposure and adverse outcomes, including necrotizing enterocolitis (NEC), bloodstream infections, meningitis, and death. RESULTS: Of 78 076 infants, 3626 (4.6%) received probiotics. Probiotic use increased over the study period and varied among neonatal intensive care units. We matched 2178 infants exposed to probiotics to 33 807 without exposure. Probiotic administration was associated with a decrease in NEC (OR 0.62, 95% CI 0.48-0.80) and death (OR 0.52, 95% CI 0.39-0.70), an increase in Candida infection (OR 2.23, 95% CI 1.29-3.85), but no increase in bloodstream infection (OR 0.86, 95% CI 0.70-1.05) or meningitis (OR 1.18, 95% CI 0.40-3.46). CONCLUSIONS: Probiotic use increased over time and was associated with decreased odds of NEC and death. Prospective, randomized-controlled studies of specific probiotic products are needed to further investigate the safety and efficacy of probiotics in preterm infants.
引用
- Gray KD, Messina JA, Cortina C, et al. Probiotic Use and Safety in the Neonatal Intensive Care Unit: A Matched Cohort Study. J Pediatr. 2020. PMID: 32418818. doi:10.1016/j.jpeds.2020.03.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。